1μg (R: reducing condition, N: non-reducing condition).
Product Details
Product Details
Product Specification
Species | Mouse |
Synonyms | NECTIN4, LNIR, PRR4, PVRL4 |
Accession | Q8R007-1 |
Amino Acid Sequence | Gly31-Ser347 with His Tag & Avi Tag at C-Terminus |
Expression System | HEK293 |
Molecular Weight | 43-47kDa (Reducing) |
Purity | >95% by SDS-PAGE & >90% by SEC-HPLC |
Conjugation | Biotin |
Tag | Avi Tag, His Tag |
Physical Appearance | Lyophilized Powder |
Storage Buffer | PBS, PH7.4, 5% trehalose |
Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. |
Reference | 1.Duan X, Zhang Z, Xu H, Zhang J, Yan Y, Yang X. Preclinical Evaluation of an Al18F-Radiolabeled Bicyclic Peptide Targeting Nectin-4. Mol Pharm. 2024 Dec 9. |
Background
Nectin-4, a member of the Nectin and nectin-like family of cell adhesion molecules, is highly expressed in normal embryonic and fetal tissues, with expression levels decreasing after reaching adulthood and being restricted in healthy adult tissues. Nectin-4 is overexpressed in various types of tumor cells and is known to promote tumor cell growth and proliferation. Solid tumors that frequently exhibit high Nectin-4 expression include bladder, pancreatic, triple-negative breast, non-small cell lung, stomach, esophageal, and ovarian cancers, among others.
Research has shown that Nectin-4 enhances tumor cell proliferation, differentiation, migration, and invasion by activating the PI3K/Akt signaling pathway, suggesting a significant role in cancer initiation and metastasis. These findings have prompted the development of drugs targeting Nectin-4 as a potential therapeutic strategy.
Picture
Picture
SDS-PAGE
SEC-HPLC
The purity of Biotinylated Nectin-4 His&Avi Tag Protein, Mouse is more than 90% determined by SEC-HPLC.
